TREELINE BIOSCIENCES: TO CONDUCT PHASE 1 DOSE ESCALATION & EXPANSION STUDY; ROCHE TO SUPPLY GLOFITAMAB & MOSUNETUZUMAB FOR SPECIFIC EXPANSION COHORTS

Reuters · 3d ago

Please log in to view news